Lastly, a troubling and highly significant surge in colistin resistance was observed between 2000 (0%) and 2020 (13.6%) ( Figure 2 , Table 3 ).
← all excerpts
Epidemiology, resistance genomics and susceptibility of <i>Acinetobacter</i> species: results from the 2020 Spanish nationwide surveillance study.
2
—
—
The sentences
Studies on the occurrence of healthcare-associated infections indicate a decreasing trend in A. baumannii ’s involvement in nosocomial infections, dropping from 2.7% in 2011 to 0.43% in 2021 and further to 0.23% in 2022 [ 24 ].